IONIS PHARMACEUTICALS INC Quarterly Debt-to-equity in % from Q2 2012 to Q2 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Ionis Pharmaceuticals Inc quarterly Debt-to-equity history and growth rate from Q2 2012 to Q2 2024.
  • Ionis Pharmaceuticals Inc Debt-to-equity for the quarter ending June 30, 2024 was 801 %, a 91.1% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 801 +382 +91.1% Jun 30, 2024
Q1 2024 717 +365 +104% Mar 31, 2024
Q4 2023 629 +332 +112% Dec 31, 2023
Q3 2023 528 +257 +95.1% Sep 30, 2023
Q2 2023 419 +140 +50.1% Jun 30, 2023
Q1 2023 352 +64.9 +22.6% Mar 31, 2023
Q4 2022 297 +16.1 +5.73% Dec 31, 2022
Q3 2022 271 -5.79 -2.1% Sep 30, 2022
Q2 2022 279 +84.1 +43.1% Jun 30, 2022
Q1 2022 287 +139 +94.1% Mar 31, 2022
Q4 2021 281 +155 +123% Dec 31, 2021
Q3 2021 276 +168 +156% Sep 30, 2021
Q2 2021 195 +87.9 +81.9% Jun 30, 2021
Q1 2021 148 +39.6 +36.6% Mar 31, 2021
Q4 2020 126 +16.2 +14.7% Dec 31, 2020
Q3 2020 108 -10.2 -8.59% Sep 30, 2020
Q2 2020 107 -28.6 -21.1% Jun 30, 2020
Q1 2020 108 -49.2 -31.2% Mar 31, 2020
Q4 2019 110 -79.7 -42% Dec 31, 2019
Q3 2019 118 -118 -50.1% Sep 30, 2019
Q2 2019 136 -126 -48.1% Jun 30, 2019
Q1 2019 157 -168 -51.6% Mar 31, 2019
Q4 2018 190 -165 -46.5% Dec 31, 2018
Q3 2018 237 -179 -43% Sep 30, 2018
Q2 2018 262 -237 -47.5% Jun 30, 2018
Q1 2018 326 -236 -42% Mar 31, 2018
Q4 2017 355 -222 -38.5% Dec 31, 2017
Q3 2017 415 -55.2 -11.7% Sep 30, 2017
Q2 2017 499 +92.4 +22.7% Jun 30, 2017
Q1 2017 561 +242 +76.1% Mar 31, 2017
Q4 2016 577 +299 +107% Dec 31, 2016
Q3 2016 470 +211 +81.6% Sep 30, 2016
Q2 2016 406 +194 +91.4% Jun 30, 2016
Q1 2016 319 +136 +74.3% Mar 31, 2016
Q4 2015 278 +125 +81.6% Dec 31, 2015
Q3 2015 259 +134 +107% Sep 30, 2015
Q2 2015 212 +90 +73.5% Jun 30, 2015
Q1 2015 183 +67.3 +58.2% Mar 31, 2015
Q4 2014 153 +31 +25.4% Dec 31, 2014
Q3 2014 125 -8.48 -6.36% Sep 30, 2014
Q2 2014 122 -26.1 -17.6% Jun 30, 2014
Q1 2014 116 -74.7 -39.3% Mar 31, 2014
Q4 2013 122 -77.8 -38.9% Dec 31, 2013
Q3 2013 133 -62.4 -31.9% Sep 30, 2013
Q2 2013 148 -43.1 -22.5% Jun 30, 2013
Q1 2013 190 Mar 31, 2013
Q4 2012 200 Dec 31, 2012
Q3 2012 196 Sep 30, 2012
Q2 2012 191 Jun 30, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.